Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome

NCT03830359 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT03830359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03830359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome
Lead sponsor
Laboratoires Thea
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2018
Completion date
February 18, 2019
Enrollment
62 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome